Revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Stryker Corp (SYK)
Price$335.08Cached quote
Net income
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $25.12B | $22.59B | $20.50B | $18.45B | $17.11B | $14.35B | $14.88B | $13.60B | $12.44B | $11.32B | $9.95B | $9.68B | $9.02B | $8.66B | $8.31B | $7.32B | $6.72B | $6.72B | $6.00B |
| Gross profit | $16.07B | $14.44B | $13.06B | $11.58B | $10.97B | $9.06B | $9.70B | $8.94B | $8.18B | $7.50B | $6.60B | $6.36B | $6.02B | $5.88B | $5.50B | $5.03B | $4.54B | $4.59B | $4.14B |
| Gross margin | 63.96% | 63.91% | 63.70% | 62.76% | 64.11% | 63.11% | 65.14% | 65.72% | 65.73% | 66.26% | 66.38% | 65.70% | 66.72% | 67.88% | 66.16% | 68.77% | 67.51% | 68.27% | 68.92% |
| Research & development | $1.62B | $1.47B | $1.39B | $1.45B | $1.24B | $984.0M | $971.0M | $862.0M | $787.0M | $715.0M | $625.0M | $614.0M | $536.0M | $471.0M | $462.0M | $394.0M | $336.0M | $367.8M | $375.3M |
| Operating expenses | $11.18B | $10.75B | $9.17B | $8.74B | $8.38B | $6.83B | $6.98B | $6.40B | $5.88B | $5.33B | $4.74B | $5.11B | $4.76B | $4.13B | $3.81B | $3.28B | $2.94B | $3.07B | $2.83B |
| Operating income | $4.89B | $3.69B | $3.89B | $2.84B | $2.58B | $2.22B | $2.71B | $2.54B | $2.30B | $2.17B | $1.86B | $1.25B | $1.26B | $1.74B | $1.69B | $1.75B | $1.59B | $1.52B | $1.31B |
| Operating margin | 19.47% | 16.33% | 18.97% | 15.40% | 15.10% | 15.49% | 18.23% | 18.65% | 18.46% | 19.21% | 18.71% | 12.88% | 13.92% | 20.11% | 20.30% | 23.92% | 23.71% | 22.61% | 21.79% |
| EBITDA | $6.46B | $5.12B | $5.23B | $4.12B | $3.86B | $3.30B | $3.76B | $3.50B | $3.16B | $2.93B | $2.45B | $1.83B | $1.77B | $2.23B | $2.17B | $2.16B | $1.98B | $1.71B | $1.49B |
| EBITDA margin | 25.72% | 22.64% | 25.51% | 22.33% | 22.54% | 22.99% | 25.24% | 25.76% | 25.36% | 25.85% | 24.64% | 18.94% | 19.59% | 25.72% | 26.09% | 29.52% | 29.44% | 25.52% | 24.76% |
| Net income | $3.25B | $2.99B | $3.17B | $2.36B | $1.99B | $1.60B | $2.08B | $3.55B | $1.02B | $1.65B | $1.44B | $515.0M | $1.01B | $1.30B | $1.34B | $1.27B | $1.11B | $1.15B | $1.02B |
| Net profit margin | 12.92% | 13.25% | 15.44% | 12.78% | 11.66% | 11.14% | 13.99% | 26.12% | 8.20% | 14.54% | 14.47% | 5.32% | 11.15% | 14.99% | 16.19% | 17.39% | 16.47% | 17.08% | 16.96% |
| Basic EPSper basic share | $8.49 | $7.86 | $8.34 | $6.23 | $5.29 | $4.26 | $5.57 | $9.50 | $2.73 | $4.40 | $3.82 | $1.36 | $2.66 | $3.41 | $3.48 | $3.21 | $2.79 | $2.81 | $2.48 |
| Diluted EPSper diluted share | $8.40 | $7.76 | $8.25 | $6.17 | $5.21 | $4.20 | $5.48 | $9.34 | $2.68 | $4.35 | $3.78 | $1.34 | $2.63 | $3.39 | $3.45 | $3.19 | $2.77 | $2.78 | $2.44 |
Owners
Reported shareholders
7.15%of listed shares
BlackRock, Inc.27.41M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 7.15%27.41M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 5.88%22.54M shares |
JPMORGAN CHASE & CO | 4.50%17.26M shares |
STATE STREET CORP | 4.05%15.53M shares |
GREENLEAF TRUST | 3.97%15.23M shares |
STRYKER RONDA E | ≈3.77%14.47M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 3.11%11.92M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 2.13%8.17M shares |
WELLINGTON MANAGEMENT GROUP LLP | 2.13%8.17M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.04%7.82M shares |
MORGAN STANLEY | 1.55%5.96M shares |
ALLIANCEBERNSTEIN L.P. | 1.28%4.93M shares |
NORGES BANK | 1.28%4.89M shares |
BANK OF AMERICA CORP /DE/ | 1.16%4.46M shares |
Bank of New York Mellon Corp | 0.93%3.55M shares |
ROYAL BANK OF CANADA | 0.91%3.48M shares |
NORTHERN TRUST CORP | 0.87%3.33M shares |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.86%3.28M shares |
AMERIPRISE FINANCIAL INC | 0.85%3.27M shares |
First Western Trust Bank | 0.79%3.02M shares |
Percentages use 383.57M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Oct 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Aug 21, 2026Form 4 | Crotty Dylan BramGroup President | SellCommon Stock · indirect | 441 | $328.61 | $144.9K | 6.1K |
| Aug 19, 2026Form 4 | STRYKER RONDA EDirector | SellCommon Stock · indirect | 805 | $343.47 | $276.5K | 2.25M |
| Aug 19, 2026Form 4 | STRYKER RONDA EDirector | SellCommon Stock · indirect | 3.9K | $342.80 | $1.32M | 2.25M |
| Aug 19, 2026Form 4 | STRYKER RONDA EDirector | SellCommon Stock · indirect | 3.3K | $341.84 | $1.12M | 2.26M |
| Aug 19, 2026Form 4 | STRYKER RONDA EDirector | SellCommon Stock · indirect | 16.6K | $340.71 | $5.66M | 2.26M |
Community posts
Stryker completes ZuriMED acquisition to broaden its shoulder-repair offering
Stryker ($SYK) completed its acquisition of privately held ZuriMED, adding FiberLocker technology to its sports medicine business. The commercialized product is used to augment rotator cuff repair and is designed to increase the mechanical ...
